Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 11, 2008, Pages 1268-1273

  Ludwig, Janne ^a   Binder, A ^a   Steinmann, J ^a   Wasner, G ^a   Baron, R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLODYNIA; ARTICLE; CEREBROSPINAL FLUID; CHEMOLUMINESCENCE; CLINICAL ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRONEUROGRAPHY; ENZYME ASSAY; FEMALE; HUMAN; MALE; NERVE FIBER; NEUROPATHIC PAIN; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; CYANOCOBALAMIN DEFICIENCY; DEMOGRAPHY; DIABETES MELLITUS; DISABILITY; HEALTH STATUS; HOSPITALIZATION; MIDDLE AGED; PARESTHESIA; PYRIDOXINE DEFICIENCY; THIAMINE DEFICIENCY;

DEMOGRAPHY; DIABETES MELLITUS; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PARESTHESIA; POLYNEUROPATHIES; SEVERITY OF ILLNESS INDEX; THIAMINE DEFICIENCY; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY;

EID: 55249112003     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.134528     Document Type: Article

References (39)

1. Said G. Diabetic neuropathy - a review. Nat Clin Pract Neurol 2007;3:331-40.
2. Youle M, Osio M. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 2007;8:241-50.
3. Chen X, Levine JD. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat. Mol Pain 2007;3:5.
4. Dotevall L, Eliasson T, Hagberg L, et al. Pain as presenting symptom in Lyme neuroborreliosis. Eur J Pain 2003;7:235-9.
5. Heuss D, Schlotter-Weigel B, Sommer C. [Diagnosis and therapy of vasculitic neuropathy. Consensus statement of the German Centers for Neuromuscular Disease]. Fortschr Neurol Psychiatr 2003;71:172-86.
6. Baron R. Mechanisms of Disease: Neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2006;2:95-106.
7. Woolf CJ. The pathophysiology of peripheral neuropathic pain-abnormal peripheral input and abnormal central processing. Acta Neurochir Suppl (Wien) 1993;58:125-30.
8. Taskinen HS, Olsson T, Bucht A, et al. Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J Neuroimmunol 2000;102:17-25.
9. Kleinschnitz C, Brinkhoff J, Zelenka M, et al. The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol 2004;149:77-83.
10. Winkelstein BA, Rutkowski MD, Sweitzer SM, et al. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 2001;439:127-39.
11. Lee HL, Lee KM, Son SJ, et al. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004;15:2807-11.
12. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002;82:981-1011.
13. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int 2004;45:389-95.
14. Zelenka M, Schafers M, Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005;116:257-63.
15. Reeve AJ, Patel S, Fox A, et al. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 2000;4:247-57.
16. Empl M, Renaud S, Erne B, et al. TNF-alpha expression in painful and nonpainful neuropathies. Neurology 2001;56:1371-7.
17. Uceyler N, Rogausch JP, Toyka KV, et al. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007;69:42-9.
18. Alexander GM, van Rijn MA, van Hilten JJ, et al. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 2005;116:213-9.
19. Alexander GM, Perreault MJ, Reichenberger ER, et al. Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome. Brain Behav Immun 2007;21:668-76.
20. Rivner MH, Swift TR, Malik K. Influence of age and height on nerve conduction. Muscle Nerve 2001;24:1134-41.
21. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002;26:173-88.
22. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006;123:231-43.
23. Espinoza M, Aguilera A, Auxiliadora Bajo M, et al. Tumor necrosis factor alpha as a uremic toxin: correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients. Adv Perit Dial 1999;15:82-6.
24. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002;22:3052-60.
25. Siebert H, Bruck W. The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice. Brain Res 2003;960:152-6.
26. Osamura N, Ikeda K, Ito T, et al. Induction of interleukin-6 in dorsal root ganglion neurons after gradual elongation of rat sciatic nerve. Exp Neurol 2005;195:61-70.
27. Bolin LM, Verity AN, Silver JE, et al. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995;64:850-8.
28. Gadient RA, Otten UH. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-90.
29. Skundric DS, Lisak RP. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp Diabesity Res 2003;4:303-12.
30. Xu G, Pierson CR, Murakawa Y, et al. Altered tubulin and neurofilament expression and impaired axonal growth in diabetic nerve regeneration. J Neuropathol Exp Neurol 2002;61:164-75.
31. Lindenlaub T, Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (Berl) 2003;105:593-602.
32. Schmidt B, Toyka KV, Kiefer R, et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996;19:474- 87.
33. Watkins LR, Goehler LE, Relton J, et al. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 1995;692:244-50.
34. Cunha FQ, Poole S, Lorenzetti BB, et al. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-4.
35. Rommel O, Gehling M, Dertwinkel R, et al. Hemisensory impairment in patients with complex regional pain syndrome. Pain 1999;80:95-101.
36. Janig W, Baron B. Complex regional pain syndrome is a disease of the central nervous system. Clin Auton Res 2002;12:150-64.
37. McCabe CS, Haigh RC, Halligan PW, et al. Referred sensations in patients with complex regional pain syndrome type 1. Rheumatology (Oxford) 2003;42:1067-73.
38. Maihofner C, Handwerker HO, Birklein F. Functional imaging of allodynia in complex regional pain syndrome. Neurology 2006;66:711-7.
39. Maihofner C, Baron R, Decol R, et al. The motor system shows adaptive changes in complex regional pain syndrome. Brain 2007;130:2671-87.